Johnson & Johnson (JNJ) Stock Drops Despite Earnings Beat and Strong 2026 Outlook

TLDR Johnson & Johnson beat Q4 estimates with adjusted earnings of $2.46 per share versus $2.42 expected and sales of $24.56 billion versus $24.1 billion forecast Stock fell 1.7% in premarket trading despite the earnings beat, likely due to profit-taking after shares gained 43% in 2025 Stelara sales dropped 48% in Q4 after losing patent [...]

The post Johnson & Johnson (JNJ) Stock Drops Despite Earnings Beat and Strong 2026 Outlook appeared first on Blockonomi.